Retatrutide is a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By boosting these receptors, https://hannalhmr781608.ssnblog.com/35147836/retatrutide-a-promising-new-treatment-for-obesity